285 related articles for article (PubMed ID: 32911281)
1. Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature review.
Sharma A; Mohammad AJ; Turesson C
Semin Arthritis Rheum; 2020 Oct; 50(5):1040-1048. PubMed ID: 32911281
[TBL] [Abstract][Full Text] [Related]
2. Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015.
Crowson CS; Matteson EL
Semin Arthritis Rheum; 2017 Oct; 47(2):253-256. PubMed ID: 28551169
[TBL] [Abstract][Full Text] [Related]
3. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
Buttgereit F; Dejaco C; Matteson EL; Dasgupta B
JAMA; 2016 Jun; 315(22):2442-58. PubMed ID: 27299619
[TBL] [Abstract][Full Text] [Related]
4. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
Albrecht K; Huscher D; Buttgereit F; Aringer M; Hoese G; Ochs W; Thiele K; Zink A
Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397
[TBL] [Abstract][Full Text] [Related]
5. Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases.
Pujades-Rodriguez M; Duyx B; Thomas SL; Stogiannis D; Smeeth L; Hemingway H
Heart; 2016 Mar; 102(5):383-9. PubMed ID: 26786818
[TBL] [Abstract][Full Text] [Related]
6. Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: Clinical features and epidemiological data.
Pamuk ON; Dönmez S; Karahan B; Pamuk GE; Cakir N
Clin Exp Rheumatol; 2009; 27(5):830-3. PubMed ID: 19917168
[TBL] [Abstract][Full Text] [Related]
7. Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy.
Salvarani C; Macchioni P; Zizzi F; Mantovani W; Rossi F; Castri C; Capozzoli N; Baricchi R; Boiardi L; Chiaravalloti F
Arthritis Rheum; 1991 Mar; 34(3):351-6. PubMed ID: 2003856
[TBL] [Abstract][Full Text] [Related]
8. Comorbidities in polymyalgia rheumatica: a systematic review.
Partington R; Helliwell T; Muller S; Abdul Sultan A; Mallen C
Arthritis Res Ther; 2018 Nov; 20(1):258. PubMed ID: 30458857
[TBL] [Abstract][Full Text] [Related]
9. Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.
Schmidt J; Warrington KJ
Drugs Aging; 2011 Aug; 28(8):651-66. PubMed ID: 21812500
[TBL] [Abstract][Full Text] [Related]
10. Are polymyalgia rheumatica and giant cell arteritis the same disease?
Cantini F; Niccoli L; Storri L; Nannini C; Olivieri I; Padula A; Boiardi L; Salvarani C
Semin Arthritis Rheum; 2004 Apr; 33(5):294-301. PubMed ID: 15079760
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of giant cell arteritis and polymyalgia rheumatica in a UK primary care population.
Yates M; Graham K; Watts RA; MacGregor AJ
BMC Musculoskelet Disord; 2016 Jul; 17():285. PubMed ID: 27421253
[TBL] [Abstract][Full Text] [Related]
12. Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study.
Paskins Z; Whittle R; Sultan AA; Muller S; Blagojevic-Bucknall M; Helliwell T; Hider S; Roddy E; Mallen C
BMC Med; 2018 Jan; 16(1):4. PubMed ID: 29316928
[TBL] [Abstract][Full Text] [Related]
13. Subclinical giant cell arteritis in polymyalgia rheumatica: Concurrent conditions or a common spectrum of inflammatory diseases?
Salvarani C; Padoan R; Iorio L; Tomelleri A; Terrier B; Muratore F; Dasgupta B
Autoimmun Rev; 2024 Jan; 23(1):103415. PubMed ID: 37625672
[TBL] [Abstract][Full Text] [Related]
14. Development of Giant Cell Arteritis after Treating Polymyalgia or Peripheral Arthritis: A Retrospective Case-control Study.
Liozon E; de Boysson H; Dalmay F; Gondran G; Bezanahary H; Fauchais AL; Ly KH
J Rheumatol; 2018 May; 45(5):678-685. PubMed ID: 29545449
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of self-reported diagnoses of polymyalgia rheumatica and giant cell arteritis in the French prospective E3N- EPIC cohort: A validation study.
Barde F; Ascione S; Pacoureau L; Macdonald C; Salliot C; Boutron-Ruault MC; Seror R; Nguyen Y
Semin Arthritis Rheum; 2024 Feb; 64():152298. PubMed ID: 38000317
[TBL] [Abstract][Full Text] [Related]
16. Incidence of cardiovascular events in polymyalgia rheumatica and giant cell arteritis amongst an Asian population: Propensity score matched cohort study.
Kobayashi D; Suyama Y; Osugi Y; Arioka H; Takahashi O; Kuriyama N
Int J Rheum Dis; 2018 Jun; 21(6):1314-1321. PubMed ID: 29879315
[TBL] [Abstract][Full Text] [Related]
17. The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, south Norway: a prospective study 1987-94.
Gran JT; Myklebust G
J Rheumatol; 1997 Sep; 24(9):1739-43. PubMed ID: 9292797
[TBL] [Abstract][Full Text] [Related]
18. HLA-DRB1 allele distribution in polymyalgia rheumatica and giant cell arteritis: influence on clinical subgroups and prognosis.
Martínez-Taboda VM; Bartolome MJ; Lopez-Hoyos M; Blanco R; Mata C; Calvo J; Corrales A; Rodriguez-Valverde V
Semin Arthritis Rheum; 2004 Aug; 34(1):454-64. PubMed ID: 15305244
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and characteristics of subclinical giant cell arteritis in polymyalgia rheumatica.
De Miguel E; Macchioni P; Conticini E; Campochiaro C; Karalilova R; Monti S; Ponte C; Klinowski G; Monjo-Henry I; Falsetti P; Batalov Z; Tomelleri A; Hocevar A
Rheumatology (Oxford); 2024 Jan; 63(1):158-164. PubMed ID: 37129541
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of polymyalgia rheumatica.
Cimmino MA; Zaccaria A
Clin Exp Rheumatol; 2000; 18(4 Suppl 20):S9-11. PubMed ID: 10948749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
